NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every industry reaches a moment when proof stops being optional. For SMX (NASDAQ:SMX), that moment has arrived. What began as molecular science has ...

All amounts are stated in United States dollars unless otherwise indicatedRevenue of $10.1 millionTotal Contract Value (“TCV”)(1) bookings of $13.4 millionGross margin of 55%Adjusted EBITDA(1) loss of ...